Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,890 total articles
Nu Holdings (NU) combines dominant market share in Brazil, broad user growth across Latin America and a newly obtained U.S. banking charter with improving monetization. At a $80.8B market cap and current price near $16.67, the risk/reward favors a long position targeting a re-rating as macro and political noise subside. Trade plan included for a lo…
RLX Technology is a Chinese e-vapor manufacturer trading at $2.405 with a $2.93B market cap. The bull case is straightforward: management is pursuing international expansion that could lift average selling prices and margins, while current technicals and a modest valuation leave room for a re-rate. This trade idea lays out an actionable mid-term lo…
CareTrust REIT (CTRE) has been re-rated by the market after sizable acquisition activity, dividend increases and rapid revenue growth in recent quarters. The stock shows bullish technicals and manageable leverage, supporting a mid-term swing trade to $45. Entry $40.91, stop $38.50, target $45.00 — horizon: mid term (45 trading days).
Realty Income is the classic income anchor: a $61.6B net-lease REIT with 15,500 properties and a near-5% yield. The business delivers predictable cash flow through single-tenant leases and monthly payouts. At $66.17 today, the stock offers steady income, improving technicals, and a valuation that — while not cheap on a P/E basis — looks reasonable …
Jazz Pharmaceuticals is trading up sharply after pipeline and competitive developments have reduced near-term regulatory and commercial overhang for its oxybate franchise. The setup offers a momentum swing with defined risk: entry near the breakout, stop under key technical support, and a target that captures re-rating possibilities as free cash fl…
Nutex Health (NUTX) trades at roughly a $760M market cap and shows solid cash flow and ROE on headline numbers. That said, an alleged $387 million receivables issue tied to third‑party arbitration claims creates a binary outcome: a material write‑down that could cut equity value sharply, or a policy intervention that limits clawbacks and stabilizes…
Zscaler (ZS) is positioned to capture accelerating demand for AI-aware security. Recent M&A and a sticky enterprise footprint, paired with strong free cash flow, create a favorable risk-reward for aggressive growth investors willing to accept volatility. This trade lays out a long entry at $156.39, a conservative target at $260, and a stop at $135 …
Imperial Petroleum (IMPP) trades at a steep discount to tangible shipping earnings and book value. A $60M registered direct offering and recurring preferred dividends signal ample liquidity and disciplined capital allocation. We recommend a mid-term swing long with defined entry, stop and target levels to capture a rerating toward the offering pric…
Taylor Morrison (TMHC) combines value-level multiples (P/E ~8, P/B ~1) with solid free cash flow and a manageable debt load. With housing sentiment typically improving into spring and short interest elevated, a disciplined mid-term trade targeting a move back toward the 52-week high is attractive. Entry at $65.00, stop at $60.00, target $73.00 — mi…
Agree Realty (ADC) trades near its 52-week high but still offers a compelling mix of yield, predictable cash flow and conservative balance sheet metrics. With a $9.55B market cap, low leverage (debt/equity ~0.47), and a monthly dividend yielding about 3.9%, I view ADC as a long trade for investors who want income plus upside. My plan: enter at $79.…
Abbott's share pullback has created an attractive entry for a mid-term swing trade. The company combines durable cash flow - $7.4B in free cash flow - with a conservative balance sheet, a 54-year streak of dividend raises, and near-term catalysts (Exact Sciences acquisition close, new heart-rhythm approval) that can re-rate the multiple. Valuation …
Nebius is rapidly scaling AI-centric cloud infrastructure and building a platform stack that includes data, dev tools, and reskilling. The market is focused on GPUs, but Nebius' $20B+ backlog, a $3B Meta contract, and sky-high growth expectations justify a tactical long swing. Entry $106.08, target $140.00, stop $90.00.
Novo Nordisk plunged to a 52-week low after a disappointing head-to-head obesity trial and aggressive price cuts, but the stock now trades at roughly $169B market cap and a PE near 11. We upgrade to a buy for a tactical swing trade: entry $38.00, stop $34.00, target $52.00 over a mid-term (45 trading days) horizon based on oversold technicals, divi…
Gaming and Leisure Properties (GLPI) offers an attractive entry point for income-focused investors. The REIT yields about 6.46% today, is trading near $48, and has just closed an accretive $700M acquisition and priced an $800M 5.625% note to simplify its capital stack. With solid ROE, positive operating metrics, and indications management is using …
Insteel (IIIN) is a small-cap steel reinforcing products maker showing sustained pricing power and margin upside despite cyclical volume swings. With a market cap of $734,153,740, P/E around 15.4, no debt and improving gross margins, the stock merits a tactical upgrade for a mid-term swing trade. Entry at current levels captures momentum while a co…
Mercury General screens as a classic insurance recovery trade: manageable balance sheet, strong free cash flow ($990.9M), attractive multiples (EV/EBITDA 6.6, P/E ~11.2), and improving underwriting after a year of elevated catastrophe headlines. I recommend a long entry with a clear stop and a multi-horizon target plan.
CAVA rallied into optimism around new-restaurant growth and industry sentiment, but valuation and cash-flow metrics suggest most upside from openings is already priced. This trade idea recommends a short-swing position sized for conviction: entry $86.00, target $72.00, stop $91.00, horizon mid term (45 trading days).
Equitable's shares trade near the low end of their range after private-credit jitters. The company has meaningful free cash flow, a $1B buyback and recent capital actions that reduce tail risk. We view the current price as a manageable entry for a long trade over a 180 trading-day horizon with a defined stop and a reasonable upside target tied to m…
Netflix has retraced sharply from its 2025 highs and now trades within a stone's throw of the recent $75 low. Fundamentals remain strong - double-digit revenue growth, expanding margins, and a fast-growing ad business - while valuation metrics (EV/EBITDA ~8.9, trailing P/E ~32x) are reasonable relative to growth. This trade idea lays out a clear en…
Accenture has been punished in the market: the stock is down sharply from its 52-week high and momentum indicators are deeply oversold. Yet the business still generates strong free cash flow, sports a 24.7% return on equity, and carries light leverage. This trade idea takes a pragmatic long stance over a mid-term (45 trading days) horizon, using di…
LifeMD (LFMD) is a small-cap telehealth operator priced like a turnaround story but trading with real free cash flow. With a market cap near $132M, EV of roughly $105M and free cash flow of about $10.7M, the stock offers a compelling risk-reward for disciplined traders. This is an actionable long trade with defined entry, stop and target tied to ne…
<p>Costco trades at roughly 53x earnings today, about twice Amazon's P/E. That premium looks large on the surface, but a closer look at Costco's recurring membership income, cash generation, and capital-light balance sheet shows why investors might rationally tolerate a higher multiple. This note upgrades Costco to a buy from a trade perspective an…
Netflix is showing classic operating-leverage dynamics: mid-teens top-line growth, near-30% operating margins and a rapidly scaling ad business. With EV/EBITDA under 9 and free cash flow north of $9.4B, the setup is attractive for a long trade over the next 180 trading days, provided the Warner Bros. deal noise is navigated and macro liquidity rema…
Sinclair’s Q4 beat and a 2026 guide that calls for $700-740M in Adjusted EBITDA plus at least $333M in political advertising revenue shift the risk/reward in favor of buyers. The stock yields north of 7% and generates meaningful free cash flow, providing a margin of safety if secular pressures persist. This trade idea takes a mid-term view to captu…
Farmers & Merchants Bancorp (FMCB) looks like a conservative regional bank trade for 2026: strong earnings, an established dividend track record, and an expanded buyback program support a modest re-rating. Thin liquidity and near-term technical overbought readings argue for a disciplined entry, a modest stop, and a patient long-term horizon.
